Femipro Official Website › Disclaimer
Femipro Disclaimer
Femipro is a dietary supplement, not a drug, and it is not FDA-approved. Nothing on this website diagnoses, treats, cures or prevents any disease. The research cited here concerns individual ingredients at amounts this label does not publish, not the finished capsule, which has never been the subject of a clinical trial.
Five disclosures, each with the reason behind it rather than a wall of boilerplate.
The FDA statement on Femipro
The sentence, and what it actually means.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
That sentence is printed on the bottle and in the footer of every page on this website. It is not decoration and it is not a formality. It is the boundary within which a dietary supplement may be sold at all.
Under DSHEA, the FDA has no authority to approve dietary supplements before they are marketed, and its dietary supplements hub sets out what that framework does and does not cover. The NIH Office of Dietary Supplements puts the consumer version of the same point plainly: supplements are not reviewed for safety or effectiveness before they are sold. There is no pre-market review for a product like this, which means no regulator has examined this capsule and concluded anything about it. A supplement may make structure and function claims, which describe support for a normal function. It may not make disease claims. The three lines printed on this bottle, bladder control support, microbiome balance and a healthy urinary system, are structure and function claims, and everything on this website stays inside them.
You will notice this website does not use the asterisk convention, where a symbol attaches to each claim and points at the statement. The statement appears in full in the footer of every page instead. That is a deliberate choice: an asterisk drifting through a sentence with no footnote within a screen of it is worse than no symbol at all, and this way the disclosure is on the page whether or not anybody follows a marker.
What the research cited on this Femipro website is, and is not
Thirty sources, and none of them is about this capsule.
This website cites around thirty sources. Every PubMed identifier was checked against the database record before it was used, and the government pages were opened in a browser rather than trusted to an automated check, because several of them refuse scripted requests outright and fda.gov does it with a 404, the same answer a genuinely dead page gives. Every link here was opened and read.
What none of those sources is, is a study of Femipro. Every one concerns an ingredient, usually alone, usually at a dose this label does not print, and sometimes by a different route of administration entirely.
| Gap | What it means |
|---|---|
| The product gap | No trial of Femipro exists. The phrase “clinically researched ingredients” on the label is carefully worded and accurate. It is not the same as a clinically researched product |
| The dose gap | Nine ingredients share two blend totals and no individual figure is published, so no ingredient here can be compared with the amount used in any study of it |
| The route gap | The two positive trials of L. crispatus delivered it as a vaginal suppository. This is a capsule you swallow, and a result obtained by one route does not transfer to another |
All three gaps are stated on the ingredients page and the how-it-works page as well, because they apply wherever an ingredient is named.
We also cite findings that do not favour this product, deliberately and at the same size as the ones that do. The Cochrane review of probiotics for preventing urinary infection is null. The REGATTA trial of uva-ursi found more pyelonephritis than the antibiotic comparator. Mimosa pudica has no human trial for any relevant outcome. A citation list assembled only from flattering results is a marketing device, not a bibliography.
This Femipro website is not medical advice
What we can tell you, what we cannot, and three situations that belong elsewhere.
Nobody at this desk is a clinician and nothing on this website is medical advice. We can tell you what is printed on a label and what a published study found. We cannot tell you what is happening in your body, whether this product is right for you, or what to do about a symptom.
Three situations belong with a clinician and not with a supplement page:
Burning that is getting worse, fever or shivering, pain in the back or flank, or blood in the urine. These can indicate an infection that has reached a kidney. A dietary supplement is not a treatment for that, and the real danger of a product like this is that it buys time somebody does not have.
The second is prescription medicine. Berberine inhibits CYP3A4 and P-glycoprotein and can raise blood levels of a long list of drugs, and the FDA warns that supplement and medicine combinations can have dangerous effects. Show the panel to a pharmacist before the first capsule. That conversation takes two minutes at a counter and no website can substitute for it.
The third is an ongoing bladder or urinary problem. MedlinePlus and NIDDK describe the types plainly, and the American College of Physicians guideline puts pelvic floor muscle training and bladder training first for the two commonest kinds. Those have better evidence than anything in this bottle and they cost nothing. Knowing which type you have changes what helps, and a capsule does not make that distinction.
Results, testimonials and the Femipro figures on this site
Five statements about numbers, and one of them is about our own.
Individual results vary. Food, sleep, fluid intake, activity and prescribed treatment all affect the outcomes this product is sold to support, and none of them stops mattering when a capsule is added.
Testimonials are buyer-supplied and are not typical. The eight lines published on the reviews page describe those individuals' own experiences. They are not evidence, they are not a promise, and the FTC states directly that consumer testimonials cannot substitute for scientific evidence.
The review figures are this desk's own order book. The score, the written count, the order count, the recommendation rate and the star split describe orders placed through this website. They are not a global rating for the product, and we would not publish one, because we have no visibility of anybody else's sales. Where our figure disagrees with the seller's, as it does on the most-bought pack, we publish ours and note the difference.
The review text is summary copy. Eight buyers carry two distinct sentences between them. We publish that as a roster and two counted themes rather than as eight testimonials, and the reviews page says so at the top rather than in a footnote.
The lot and certificate references are stock records. Lot FEM-26/FE-4936 and certificate reference FEM-4936-26-FE identify the batch this desk holds. They are not laboratory proof, this desk does not hold the certificate document, and the batch verification page says so rather than displaying a number that looks like a lab report.
The commercial relationship behind this Femipro website
We earn when you buy, and here is where to check what that has cost the copy.
Femipros earns when you buy. Order links on this website are marked as sponsored and they lead to the official checkout. That is the whole business model and it is stated on this page, on the about page and in the link markup itself.
The right response to that disclosure is not to trust us more; it is to check the places where this website argues against its own interest, because those are the only parts that cost anything to write. The pricing page recommends the smaller pack. The testing page tells vegetarians not to buy. The ingredients page grades four of five ingredients unfavourably. The timeline page points out that the guarantee is shorter than the wait. The about page lists all of them in one table so they can be checked together.
We are not the manufacturer, and we have no financial relationship with any of the researchers or institutions cited here. Where a cited source has its own interest we say so in the citation: the hydroquinone risk assessment on the safety page is noted as having been written by employees of a bearberry product manufacturer, because it was, and that is the sort of thing a reader is entitled to know without having to go and look.
Every page, every journal post, the bottle facts and the ingredients go through review by Dr. Jennifer Roelands, MD before they ship. We write these pages from the printed Femipro bottle and from the Supplement Facts panel photographed in our own stock images, cite public research for cranberry, bearberry, berberine, mimosa pudica and the named lactobacillus strains, and print “not published” wherever a figure is not disclosed rather than estimating it. This label publishes two blend totals and no individual amount, and that fact appears on every page where an ingredient is named. Where the seller’s marketing claims more than the bottle supports, we say so on the page. Corrections are made on the page itself and the review date moves forward. Write to [email protected]. Last reviewed September 2026 by Dr. Jennifer Roelands, MD.
Sources for the Femipro disclaimer
- FDA, questions and answers on dietary supplements. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements. "Under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed." View source
- FDA, dietary supplements. U.S. Food and Drug Administration. Dietary Supplements. The agency's hub for how supplements are regulated under DSHEA, including what is and is not reviewed before a product reaches the market. View source
- NIH Office of Dietary Supplements, what you need to know. National Institutes of Health, Office of Dietary Supplements. Dietary Supplements: What You Need to Know. Explains what a supplement is, what a label must carry, and that supplements are not reviewed for safety or effectiveness before they are sold. View source
- FDA, mixing medicines and supplements. U.S. Food and Drug Administration. Mixing Medications and Dietary Supplements Can Endanger Your Health. View source
- FTC health products compliance guidance. Federal Trade Commission. Health Products Compliance Guidance. Requires competent and reliable scientific evidence for health claims, and states that consumer testimonials cannot substitute for it. View source
- NCCIH, using dietary supplements wisely. National Center for Complementary and Integrative Health. Using Dietary Supplements Wisely. National Institutes of Health. View source
- Cochrane review, probiotics and UTI, 2015. Schwenger EM, Tejani AM, Loewen PS. Probiotics for preventing urinary tract infections in adults and children. Cochrane Database of Systematic Reviews. 2015;(12):CD008772. View source
- REGATTA trial, uva-ursi versus fosfomycin, 2021. Gagyor I, Hummers E, Schmiemann G, et al. Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: a randomized controlled trial. Clinical Microbiology and Infection. 2021;27(10):1441-1447. View source
- American College of Physicians guideline, 2014. Qaseem A, Dallas P, Forciea MA, et al. Nonsurgical management of urinary incontinence in women: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine. 2014;161(6):429-440. View source
- MedlinePlus, urinary incontinence. MedlinePlus. Urinary Incontinence. National Library of Medicine, National Institutes of Health. View source
- NIDDK, bladder control problems in women. National Institute of Diabetes and Digestive and Kidney Diseases. Bladder Control Problems (Urinary Incontinence). National Institutes of Health. View source
Order Femipro with the disclosures read
A supplement, not a drug. No trial of the finished product. Individual amounts not published. If that is a trade you will take, the guarantee covers the rest.
$49 to $69 a bottle · 60 days to change your mind
Order Femipro On The Official WebsiteOne-time payment, no subscription · free US shipping · 60-day money-back guarantee · lot FEM-26/FE-4936 · tracking and refunds +1 (302) 200-3480